Header Logo

Sefer Gezer

Concepts (155)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Myelodysplastic Syndromes
15
2004
33
0.600
Why?
Antiphospholipid Syndrome
1
2003
5
0.220
Why?
Bone Marrow
10
2001
81
0.200
Why?
Apoptosis
8
1999
205
0.180
Why?
Thrombosis
1
2021
58
0.180
Why?
Thalidomide
3
2004
6
0.160
Why?
Tumor Necrosis Factor-alpha
4
2004
192
0.130
Why?
Leukemia, Myeloid, Acute
4
2001
50
0.130
Why?
Antineoplastic Agents
3
2004
190
0.120
Why?
Leukemia, Promyelocytic, Acute
2
1998
5
0.120
Why?
Tretinoin
2
1998
15
0.120
Why?
Interphase
4
1990
5
0.110
Why?
Blood Coagulation
1
2011
20
0.090
Why?
Genetic Testing
1
2011
59
0.090
Why?
Cytokines
4
2001
232
0.090
Why?
Venous Thrombosis
1
2011
46
0.090
Why?
Pulmonary Embolism
1
2011
64
0.080
Why?
Hematopoietic Stem Cells
4
1999
11
0.080
Why?
Biomarkers
2
2011
601
0.080
Why?
Humans
26
2021
28573
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2000
242
0.080
Why?
Lymphohistiocytosis, Hemophagocytic
1
2008
9
0.080
Why?
Male
13
2011
15403
0.060
Why?
Cell Cycle
3
1997
34
0.060
Why?
Bromodeoxyuridine
3
1997
10
0.060
Why?
Antibodies, Monoclonal
2
2004
199
0.060
Why?
Proto-Oncogenes
1
2004
4
0.060
Why?
Arsenicals
1
2004
12
0.060
Why?
Oxides
1
2004
18
0.060
Why?
Immunosuppressive Agents
2
2004
140
0.060
Why?
Female
11
2011
15823
0.060
Why?
Drug Resistance, Neoplasm
1
2004
63
0.050
Why?
Aged
11
2011
9344
0.050
Why?
Transcription Factors
1
2004
172
0.050
Why?
Arthroplasty, Replacement, Knee
1
2011
625
0.050
Why?
Pilot Projects
4
2011
438
0.050
Why?
Transforming Growth Factor beta
3
2001
93
0.050
Why?
DNA-Binding Proteins
1
2004
274
0.050
Why?
Aged, 80 and over
7
2011
4901
0.050
Why?
Prevalence
1
2003
467
0.050
Why?
Cytarabine
3
2001
11
0.050
Why?
Middle Aged
10
2011
9324
0.050
Why?
Bone Marrow Cells
1
2001
51
0.050
Why?
Adult
6
2021
8175
0.050
Why?
Blood Transfusion
1
2001
67
0.050
Why?
DNA, Neoplasm
2
1998
20
0.040
Why?
Anemia
1
2001
94
0.040
Why?
Connective Tissue
2
1996
23
0.040
Why?
Palliative Care
1
2000
109
0.040
Why?
Cytogenetic Analysis
3
2004
5
0.040
Why?
Remission Induction
3
2004
90
0.040
Why?
Hematopoiesis
4
2001
13
0.040
Why?
Ecchymosis
1
1998
2
0.040
Why?
Cell Division
4
2001
83
0.040
Why?
Idoxuridine
1
1997
2
0.040
Why?
Severity of Illness Index
1
2021
990
0.040
Why?
Cell Lineage
3
2004
24
0.040
Why?
Cysteine Endopeptidases
1
1996
11
0.030
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
1996
17
0.030
Why?
Leukemia, Myeloid
2
1995
4
0.030
Why?
Endopeptidases
1
1996
18
0.030
Why?
DNA
3
1997
104
0.030
Why?
Treatment Outcome
5
2004
3621
0.030
Why?
Macrophages
3
2001
108
0.030
Why?
Tumor Cells, Cultured
2
1992
120
0.030
Why?
Phenotype
2
2011
311
0.030
Why?
Risk Factors
2
2011
2414
0.020
Why?
Time Factors
2
2001
1500
0.020
Why?
Hemoglobins
2
2001
78
0.020
Why?
Mitoxantrone
2
2001
4
0.020
Why?
Blood Cell Count
2
2001
12
0.020
Why?
Pedigree
1
2011
67
0.020
Why?
Chi-Square Distribution
1
2011
146
0.020
Why?
Amifostine
2
2000
3
0.020
Why?
Monosomy
1
1990
1
0.020
Why?
Leukemia, Monocytic, Acute
1
1990
4
0.020
Why?
Chromosome Deletion
1
1990
16
0.020
Why?
Preoperative Care
1
2011
125
0.020
Why?
Anticoagulants
1
2011
90
0.020
Why?
Case-Control Studies
2
2001
599
0.020
Why?
Antigens, CD34
2
2001
14
0.020
Why?
Patient Selection
1
2011
207
0.020
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
1989
9
0.020
Why?
Antigens, Neoplasm
1
1989
39
0.020
Why?
Nucleoproteins
1
1988
2
0.020
Why?
Superoxides
1
1988
25
0.020
Why?
Genetic Predisposition to Disease
1
2011
392
0.020
Why?
Fatal Outcome
1
2008
57
0.020
Why?
Disease Progression
2
2004
722
0.020
Why?
Cell Differentiation
1
1988
136
0.020
Why?
Risk Assessment
1
2011
676
0.020
Why?
Chicago
1
2011
942
0.020
Why?
DNA Fragmentation
2
1996
5
0.020
Why?
DNA Replication
2
1996
10
0.020
Why?
S Phase
2
1999
10
0.020
Why?
Interleukin-1
2
1996
49
0.020
Why?
Surveys and Questionnaires
1
2011
1222
0.020
Why?
Anemia, Refractory
1
2004
1
0.010
Why?
Pancytopenia
1
2004
3
0.010
Why?
Chromosome Aberrations
1
2004
14
0.010
Why?
Infliximab
1
2004
17
0.010
Why?
MDS1 and EVI1 Complex Locus Protein
1
2004
3
0.010
Why?
Zinc Fingers
1
2004
12
0.010
Why?
Spleen
1
2004
34
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
140
0.010
Why?
Drug Therapy, Combination
1
2004
184
0.010
Why?
Acute Disease
2
1995
208
0.010
Why?
Patient Compliance
1
2004
166
0.010
Why?
Lymphokines
1
2001
9
0.010
Why?
Platelet Count
1
2001
16
0.010
Why?
Transforming Growth Factor alpha
1
2001
8
0.010
Why?
Vascular Endothelial Growth Factors
1
2001
14
0.010
Why?
Endothelial Growth Factors
1
2001
10
0.010
Why?
Coculture Techniques
1
2001
28
0.010
Why?
Fetal Blood
1
2001
13
0.010
Why?
Endothelium
1
2001
12
0.010
Why?
Adipocytes
1
2001
21
0.010
Why?
Microscopy, Electron
1
2001
67
0.010
Why?
Cell Culture Techniques
1
2001
32
0.010
Why?
Maximum Tolerated Dose
1
2001
13
0.010
Why?
Fibroblasts
1
2001
58
0.010
Why?
Stromal Cells
1
2001
32
0.010
Why?
Vascular Endothelial Growth Factor A
1
2001
72
0.010
Why?
Drug Administration Schedule
1
2001
166
0.010
Why?
Immunohistochemistry
1
2001
364
0.010
Why?
Radiation-Protective Agents
1
2000
3
0.010
Why?
Anorexia
1
2000
3
0.010
Why?
Pentoxifylline
1
2000
6
0.010
Why?
Ciprofloxacin
1
2000
12
0.010
Why?
Hematologic Diseases
1
2000
11
0.010
Why?
Hypotension
1
2000
29
0.010
Why?
Dexamethasone
1
2000
35
0.010
Why?
Gastrointestinal Diseases
1
2000
36
0.010
Why?
Karyotyping
1
1999
9
0.010
Why?
In Situ Nick-End Labeling
1
1999
15
0.010
Why?
Age Factors
1
2001
788
0.010
Why?
Prognosis
1
2000
826
0.010
Why?
Sialoglycoproteins
1
1996
9
0.010
Why?
Cysteine Proteinase Inhibitors
1
1996
6
0.010
Why?
Interleukin 1 Receptor Antagonist Protein
1
1996
15
0.010
Why?
Oligopeptides
1
1996
24
0.010
Why?
Caspase 1
1
1996
16
0.010
Why?
Diagnosis, Differential
1
1998
373
0.010
Why?
Leukemia
1
1996
4
0.010
Why?
Lymphoma, Non-Hodgkin
1
1996
37
0.010
Why?
Cohort Studies
1
2001
1942
0.010
Why?
Biopsy
1
1995
220
0.010
Why?
Models, Biological
1
1996
329
0.010
Why?
Tritium
1
1992
8
0.010
Why?
Adolescent
1
1999
2322
0.010
Why?
Dose-Response Relationship, Drug
1
1992
352
0.010
Why?
Metaphase
1
1990
2
0.010
Why?
Nucleic Acid Hybridization
1
1990
9
0.010
Why?
Chromosome Mapping
1
1990
44
0.010
Why?
Regeneration
1
1989
21
0.000
Why?
Gezer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (155)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_